Do out-of-pocket costs affect medication adherence in adults with rheumatoid arthritis? A systematic review.

Author: CrawfordKimberley, CrossWendy, HeidariParvaneh

Paper Details 
Original Abstract of the Article :
For individuals with a chronic condition, long-term management of their medication can be difficult and as a result non-adherence is common among this cohort. In patients with rheumatoid arthritis (RA), the introduction of biologic agents was a revolutionary treatment but the high costs of this medi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.semarthrit.2017.12.010

データ提供:米国国立医学図書館(NLM)

Out-of-Pocket Costs and Medication Adherence in Rheumatoid Arthritis

This research examines the relationship between out-of-pocket costs for medications and medication adherence in individuals with rheumatoid arthritis (RA). The study explores the impact of high medication costs on medication adherence, a critical factor in managing chronic conditions, particularly in RA. The researchers systematically review existing literature to assess the evidence linking out-of-pocket costs to medication adherence in RA patients, providing insights into the economic barriers to effective disease management.

Financial Barriers to Effective RA Treatment

The review suggests that out-of-pocket costs for medications can significantly impact medication adherence in RA patients. This underscores the importance of addressing financial barriers to ensure effective RA treatment and improve patient outcomes. The researchers highlight the need for strategies to mitigate the financial burden of medication costs, such as insurance coverage, financial assistance programs, and medication affordability initiatives.

Bridging the Gap Between Cost and Care

This research sheds light on the critical need to address the economic barriers to effective RA treatment. Imagine a camel struggling to navigate a desert with limited water sources, similarly, RA patients face challenges in accessing the medications they need due to high costs. This study encourages efforts to improve medication affordability and accessibility, ensuring that individuals with RA can receive the care they need to manage their condition.

Dr.Camel's Conclusion

This research highlights the significant impact of out-of-pocket costs on medication adherence in RA patients. It’s like a camel facing a desert with limited oases, financial barriers can impede access to essential treatment. This study underscores the need for initiatives that address medication affordability and accessibility, ensuring that individuals with RA can receive the care they need to manage their condition effectively.

Date :
  1. Date Completed 2018-11-27
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

29496225

DOI: Digital Object Identifier

10.1016/j.semarthrit.2017.12.010

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.